🔎 Trials Near Me

Dachaigh › Leukemia myeloid geur › Pennsylvania › Philadelphia

Sgrùdaidhean clionaigeach Leukemia myeloid geur ann an Philadelphia, PA

Tha 34 sgrùdaidhean airson Leukemia myeloid geur a’ lorg phàirtichean aig làraichean ann agus timcheall air Philadelphia (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Thomas Jefferson University Hospital, Philadelphia
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07437950

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

A’ fastadhÌre 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

A’ fastadhÌre 1
  • Children's Hospital of Philadelphia, Philadelphia
Suas gu aois 21 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07012044

Assessment of Geriatric Evaluations Impact on New AML Guidance

A’ fastadhSgrùdadh amharc
  • Abramson Cancer Center at University of Pennsylvania, Philadelphia
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05909501

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mìle air falbh
Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

A’ fastadhSgrùdadh amharc
  • Children's Hospital of Philadelphia, Philadelphia
Aoisean 0 gu 38 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06131801

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

A’ fastadhÌre 3
  • Thomas Jefferson University, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • Thomas Jefferson University Hospital, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
  • Thomas Jefferson University Hospital, Philadelphia
Aoisean 18 gu 59 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

A’ fastadhÌre 2
  • University of Pennsylvania/Abramson Cancer Center, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

A’ fastadhÌre 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mìle air falbh
6 Months – 21 Years · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

A’ fastadhÌre 1/2
  • University of Pennsylvania, Philadelphia
30 Days · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT04065399

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

A’ fastadhÌre 1
  • UPENN Perelman Center for Advanced Medicine, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06846606

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

A’ fastadhÌre 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mìle air falbh
Aoisean 1 gu 25 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07022678

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

A’ fastadhÌre 1/2
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mìle air falbh
Suas gu aois 22 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

A’ fastadhÌre 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours Alfred I. Dupont Hospital for Children, Wilmington · 25 mìle air falbh
29 Days – 21 Years · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

A’ fastadhÌre 3
  • University of Pennsylvania, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07007312

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

A’ fastadhÌre 2/3
  • University of Pennsylvania, Philadelphia
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06788756

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

A’ fastadhÌre 1
  • Children's Hospital of Philadelphia, Philadelphia
Aoisean 1 gu 30 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06177067

Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents

A’ fastadhÌre 2
  • Penn Medicine Abramson Cancer Center, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Iuch 2026 · NCT05442216

CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

A’ fastadhÌre 1
  • University of Pennsylvania, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT05945849

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

A’ fastadh
  • Children's Hospital of Philadelphia, Philadelphia
Suas gu aois 25 · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT03810196

CART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia

A’ fastadhÌre 1
  • Children's Hospital of Philadelphia, Philadelphia
Aoisean 0 gu 29 · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07464951

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

A’ fastadhSgrùdadh amharc
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours - Alfred I. duPont Hospital for Children, Brandywine · 21 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

A’ fastadhÌre 1/2
  • Penn Medicine - Abramson Cancer Center Perelman, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Ògmh 2026 · NCT04068597

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

A’ fastadhÌre 1
  • University of Pennsylvania, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT06222580

Massage Impact on Sleep in Pediatric Oncology

A’ fastadh
  • Children's Hospital of Philadelphia, Philadelphia
Aoisean 12 gu 21 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT06892158

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

A’ fastadhÌre 1/2
  • Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Màrt 2026 · NCT04988555

Phase IB/II of CPX-351 for Relapse Prevention in AML

A’ fastadhÌre 1/2
  • University of Pennsylvania, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Màrt 2026 · NCT04990102

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

A’ fastadhÌre 1
  • Thomas Jefferson University Hospital, Philadelphia
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 16 Màrt 2026 · NCT06994676

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

A’ fastadhÌre 1
  • Hospital of the University of Pennsylvania, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT05735184

Tazemetostat and Palbociclib With CPX-351for R/R AML

A’ fastadhÌre 1
  • Thomas Jefferson University Hospital, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT05627232

Home Blood Transfusions

A’ fastadh
  • Thomas Jefferson University Hospital, Philadelphia
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Dùbh 2025 · NCT07121140

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

A’ fastadhFàilte do shaor-thoilich fhallain
  • University of Pennsylvania, Philadelphia
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 25 Iuch 2025 · NCT05237258

Sgrùdaidhean Leukemia myeloid geur ann am bailtean eile

Sgrùdaidhean eile ann an Philadelphia

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.